Royal Sense Limited has successfully completed the allotment of 3,92,000 convertible warrants worth ₹98.39 crores. The company announced this development following its Board of Directors meeting held on December 17, 2025, marking a significant milestone in its capital raising initiative.

Warrant Allotment Details

The warrants have been issued at ₹251.00 per warrant, which includes a premium of ₹241.00 per share over the face value of ₹10.00 each. The allotment was conducted on a preferential basis to both promoter and non-promoter groups, with 25% of the total consideration already received from the respective allottees.

Regulatory Approvals and Timeline

The warrant allotment follows a comprehensive approval process. The Board of Directors initially approved the proposal on April 17, 2025, followed by shareholder approval at an Extraordinary General Meeting held on May 16, 2025. BSE Limited granted its in-principle approval through letter number LOD/PREF/KS/FIP/1288/2025-26 dated December 3, 2025.

Major Allottees Distribution

The warrants have been distributed among 22 allottees with varying allocations. The largest individual allocation went to Jyoti Asija with 19,000 warrants, followed by Vipin Pratap Singh with 15,000 warrants and Manish Kumar with 11,000 warrants.

Conversion Terms and Timeline

The warrant holders are entitled to exercise their option to convert each warrant into one fully paid-up equity share of face value ₹10.00 within 18 months from the date of allotment. The conversion will require payment of the remaining balance of the issue price for each warrant. Upon conversion, the paid-up equity share capital of the company will increase accordingly, as the current allotment does not immediately impact the existing share capital.

Corporate Governance

The allotment was approved in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable rules. The converted equity shares will rank pari-passu with the existing equity shares of the company, ensuring equal rights for all shareholders. The board meeting commenced at 5:00 p.m. and concluded at 5:45 p.m. on December 17, 2025.

Royal Sense Limited has announced a major business development with the award of a significant tender from the Central Procurement Agency under the Directorate General of Health Services. The tender was awarded to TTG Innovations Private Limited, which is the proposed transferor company set to be merged with Royal Sense Limited following regulatory approvals.

Tender Details and Scope

The contract encompasses the supply of comprehensive surgical sutures used across various medical and surgical procedures. The tender covers multiple suture types to meet diverse healthcare requirements.

Product Specifications

The tender covers a wide range of surgical sutures designed to meet stringent medical standards:

• Absorbable sutures for internal surgical procedures
• Non-absorbable sutures for external applications
• Monofilament sutures for precise surgical work
• Braided sutures for enhanced strength
• Specialty sutures for specific medical requirements

All products must comply with prescribed specifications and quality standards as mandated by the health services department.

Financial Impact and Business Outlook

The company's board has indicated significant revenue potential from this contract award. According to the disclosure, sales may increase by up to ₹100.00 crores through this tender over the contract period.

Corporate Structure Context

This tender award comes as part of ongoing corporate restructuring activities. TTG Innovations Private Limited, the entity that received the tender, is currently undergoing a merger process with Royal Sense Limited. The company has received a No Objection Certificate from BSE Limited for the proposed scheme of arrangement.

The tender represents a significant milestone for the company's healthcare products division, positioning it as a key supplier to government health services. The contract's requirement-based supply model provides flexibility while ensuring steady business flow over the two-year execution period.